February 27, 2024
admin
Zenith Drugs IPO Watch, Guidance & Subscription Status at Chanakyanipothi.com,
👉A legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.
Zenith Drugs IPO Post Listing Review :
On 27th February, the scrip is listed at Rs.110, compared to the Issue-price of Rs.79, at a premium of 39.24%. The listing has been in line with the expectations of the grey market players.
What is the last GMP of Zenith Drugs IPO?*
Premium: Rs. 35 
Subject to Rs. –
Zenith Drugs IPO Subscription
On 22 February 2024 5.00 pm (Day 4) (Closed)
Review: Response improved sharply
QIB: 2148000 Shares 106.72 T
NII: 644400 Shares 368.62 T
RII: 1503600 Shares 138.57 T
Total: 4296000 Shares 178.79 T
What is the business of Zenith Drugs?
Zenith Drugs is a pharmaceutical manufacturing and trading company based out from Indore. It has a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing of medicines. It is specialized in manufacturing high quality and affordable Medicines to support its patients in need. The Company is also into Generic Medicines and Generic Medicines are cost effective.
The company is proud to be WHO-GMP compliant, adhering to the stringent guidelines set by the World Health Organization. The commitment to quality is further demonstrated by its ISO 9001:2015 certification, obtained from a respected Euro UK certification body.
Currently, the Company is having FDA approval of more than 600 Products from Food & Drugs Administration. Out of 600 Products, 325 products are being Manufactured Regularly.
The Company is in process to establish a new factory at its land located at K. No. 72/3, 74/1/1, 75/1/1, Village Muradpura, Depalpur, Indore, Madhya Pradesh- 453001 to expand its operations. The said land is adjacent to the current factory of the Company. Once the new factory is established, the company will have huge factory setup for its operations.
Further, the Company is constantly reaping the benefits given by the Government to the MSME Segment. Our Company has received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme, 2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ? 170.04 Lakhs.
Get more information about the company @ https://zenithdrugs.com/
| Zenith Drugs IPO Details | |
| IPO opens on | 19 February 2024 |
| IPO closes on | 22 February 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 5148800 Sh /Rs 40.68 Cr |
| * Fresh Issue | 5148800 Sh /Rs 40.68 Cr |
| * Offer for Sale | – Sh /Rs – Cr |
| Market Maker Portion | 852800 Sh. |
| Net offer to Public | 4296000 Sh./Rs.33.94 Cr |
| Face Value per share | Rs. 10 |
| Price Band | Rs. 75-79 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 1600 Shares |
| Listing will at | NSE SME |
| Shares offered in Zenith Drugs IPO | ||
| Shares | Rs. (Cr) | |
| QIB (50%) | 2148000 | 16.97 |
| NII (15%) | 644400 | 5.09 |
| RII (35%) | 1503600 | 11.88 |
| Total Shares | 4296000 | 33.94 |
| Retail portion will be oversubscribed by | 940 | |
| Forms | ||
| How much Shares to Apply in Zenith Drugs IPO? | ||
| Min Retail Application | 1600 Sh | Rs. 126400 |
| Min HNI Application | 3200 Sh | Rs.252800 |
Who are the Promoters of Zenith Drugs IPO?
The promoters of the company are Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi
What are the Objects of Zenith Drugs IPO?
The Offer comprises only of a Fresh Issue of Equity shares.
The Company intends to utilize the Net Fresh Issue Proceeds for the following Objects
Purchase of Machinery & Equipments for Setting up New Unit
Existing Manufacturing Block Upgradation
Working Capital Requirements
General Corporate Purposes.
| Zenith Drugs IPO Tentative timetable | |
| IPO opens on | 19 February 2024 |
| IPO Closes on | 22 February 2024 |
| IPO Allotment on | 23 February2024 |
| Refund Initiation | 26 February 2024 |
| Credit of Shares | 26 February 2024 |
| Listing on | 27 February 2024 |
| Registered Office of the Company Zenith Drugs Limited K. No. 72 / 5, Village Muradpura NA Depalpur, Indore-453001 |
| Who is the Lead Manager of Zenith Drugs IPO? Gretex Corporate Services Limited |
| Who is the Registrar to IPO? Bigshare Services Pvt Ltd |
| Zenith Drugs IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs.in Cr | Rs.in Cr | Rs. | % | |
| 2020-21 | 9267 | 3.13 | 2.52 | 33.84 |
| 2021-22 | 115.70 | 5.15 | 2.62 | 25.96 |
| 2022-23 | 69.48 | 5.39 | 4.29 | 29.88 |
| Book Value of the Share on | 31.03.2023 | Rs 14.37 | ||
| BV of the Share at cap price | after the IPO | Rs. ? | ||
| Offer Price/upper band | Rs. 79 | |||
| Zenith Drugs IPO Key Performance indicators |
|
| Price/last EPS of 22-23 | 18.41 |
| Price/BV Ratio | 5.50 |
| Upper price/BV after IPO | |
How Zenith Drugs IPO compares with the Peers?
| As per DRHP | FV | Total Income | PE Ratio |
| In Rs. Cr | |||
| Zenith Drugs | 10 | 115 18.41 | |
| Sudarshan Pharma | 10 | 1917 | 41.11 |
| Sigachi Industries | 10 | 94 | 28.64 |
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Zenith Drugs IPO To the point Guidance
Zenith Drugs is a pharmaceutical manufacturing and trading company based out from Indore. It has a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing of medicines. It is specialized in manufacturing high quality and affordable Medicines to support its patients in need. The Company is also into Generic Medicines and Generic Medicines are cost effective.
Size: The net size of the IPO is Rs. 33.94 Cr comprising of 4296000 shares. Considering the recent IPO trends and hunger of the investors, the IPO is not very large, and it can get oversubscribed without any problem. With just 940 applications, the retail portion will get oversubscribed one time. The HNI portion is just Rs. 5.98 Cr, so huge oversubscription possible.
Financial Snapshot: The total income and net profits have remained in narrow range during last 3 years. Considering the earnings per share of 2022-23, IPO is reasonably priced. You may take some clue from the grey market and the decide.
Quicklinks
Zenith Drugs IPO GMP Detail IPO GMP today details?
Zenith Drugs IPO
Zenith Drugs IPO FAQs
What is Zenith Drugs IPO?
Zenith Drugs IPO is a SME IPO of 3360000 equity shares of the face value of Rs. 10 aggregating up to Rs.28.22 Crores. The issue is priced at Rs.80-84 per share. The minimum order quantity is 1600 Shares.
When will Zenith Drugs IPO open?
Zenith Drugs IPO opens on February ?, 2024, and closes on February ?, 2024.
What is the lot size of Zenith Drugs IPO?
Zenith Drugs IPO lot size is 1600 Shares, and the minimum amount required is Rs.134400.
How to apply for Zenith Drugs IPO?
You can apply in Zenith Drugs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
When is Zenith Drugs IPO allotment?
The finalization of Basis of Allotment for Zenith Drugs IPO will be done on February ?, 2024, and the allotted shares will be credited to your demat account by February ?, 2024.
When is Zenith Drugs IPO listing date?
Zenith Drugs IPO listing date is not yet announced. The tentative date of Zenith Drugs IPO listing is February ?, 2024.
